ShangPharma Corp. (SHP) Misses Q4 EPS by 4c

ShangPharma Corp. (NYSE: SHP) reported Q4 EPS of $1.33, $0.04 worse than the analyst estimate of $1.37. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.13 billion.

For earnings history and earnings-related data on ShangPharma Corp. (SHP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
• Investing.com’s stocks of the week